LLY

712.25

-4.67%↓

JNJ

152.87

-0.45%↓

ABBV

181.75

-1.09%↓

NVO

66.83

-2.81%↓

UNH

297.81

-2.36%↓

LLY

712.25

-4.67%↓

JNJ

152.87

-0.45%↓

ABBV

181.75

-1.09%↓

NVO

66.83

-2.81%↓

UNH

297.81

-2.36%↓

LLY

712.25

-4.67%↓

JNJ

152.87

-0.45%↓

ABBV

181.75

-1.09%↓

NVO

66.83

-2.81%↓

UNH

297.81

-2.36%↓

LLY

712.25

-4.67%↓

JNJ

152.87

-0.45%↓

ABBV

181.75

-1.09%↓

NVO

66.83

-2.81%↓

UNH

297.81

-2.36%↓

LLY

712.25

-4.67%↓

JNJ

152.87

-0.45%↓

ABBV

181.75

-1.09%↓

NVO

66.83

-2.81%↓

UNH

297.81

-2.36%↓

Search

Stevanato Group SpA

Aperta

SettoreSettore sanitario

23.14 -2.85

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

22.67

Massimo

24.07

Metriche Chiave

By Trading Economics

Entrata

25M

35M

Vendite

-74M

257M

P/E

Media del settore

48.588

54.533

EPS

0.114

Rendimento da dividendi

0.25

Margine di Profitto

13.683

Dipendenti

5,521

EBITDA

-10M

57M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+5.67% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.25%

2.41%

Utili prossimi

5 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

928M

6.8B

Apertura precedente

25.99

Chiusura precedente

23.14

Notizie sul Sentiment di mercato

By Acuity

50%

50%

187 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 mag 2025, 23:25 UTC

Azioni calde

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21 mag 2025, 21:57 UTC

Acquisizioni, Fusioni, Takeovers

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21 mag 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefónica's Operations in Uruguay

21 mag 2025, 21:01 UTC

I principali Market Mover

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21 mag 2025, 23:49 UTC

Discorsi di Mercato

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21 mag 2025, 23:37 UTC

Discorsi di Mercato

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21 mag 2025, 23:33 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21 mag 2025, 23:32 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21 mag 2025, 23:32 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21 mag 2025, 23:32 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21 mag 2025, 23:31 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21 mag 2025, 23:30 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21 mag 2025, 23:30 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21 mag 2025, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21 mag 2025, 23:28 UTC

Utili

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21 mag 2025, 23:27 UTC

Utili

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21 mag 2025, 23:23 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21 mag 2025, 23:22 UTC

Notizie principali

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

21 mag 2025, 23:22 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21 mag 2025, 23:20 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21 mag 2025, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21 mag 2025, 23:04 UTC

Notizie principali

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

21 mag 2025, 21:46 UTC

Notizie principali

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

21 mag 2025, 21:42 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21 mag 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefónica's Ops in Uruguay

21 mag 2025, 21:07 UTC

Notizie principali

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21 mag 2025, 21:06 UTC

Acquisizioni, Fusioni, Takeovers

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

5.67% in crescita

Previsioni per 12 mesi

Media 25.7 USD  5.67%

Alto 28 USD

Basso 23.5 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

4

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

187 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.